View in EDS

Utilization of Intravenous Posaconazole in Pediatric Patients Undergoing Hematopoietic Stem Cell Transplant.

Saved in:
Bibliographic Details
Title: Utilization of Intravenous Posaconazole in Pediatric Patients Undergoing Hematopoietic Stem Cell Transplant.
Authors: Kusoski C; Division of Pharmacy, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio. Electronic address: carolyn.kusoski@cchmc.org., Mehta PA; Division of Bone Marrow Transplantation & Immune Deficiency, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio., Markham J; Division of Pharmacy, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio; Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio., Zhao J; Clinical Mass Spectrometry, Division of Pathology and Laboratory Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio., Setchell KDR; Clinical Mass Spectrometry, Division of Pathology and Laboratory Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio., Murphy M; Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio., Teusink-Cross A; Division of Pharmacy, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
Source: Transplantation and cellular therapy [Transplant Cell Ther] 2025 Dec; Vol. 31 (12), pp. 1033.e1-1033.e11. Date of Electronic Publication: 2025 Sep 03.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101774629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-6367 (Electronic) Linking ISSN: 26666367 NLM ISO Abbreviation: Transplant Cell Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2666-6367
DOI:10.1016/j.jtct.2025.09.006